Hydroxyzine Eql Pharma

Hydroxyzine Hydrochloride, the active ingredient in Hydroxyzine Eql Pharma, is a first‑generation antihistamine presented as an oral formulation for oral use. It is employed to relieve symptoms of allergic conditions, manage anxiety, provide sedation, and control nausea and vomiting in adult patients. GNH USA supplies Hydroxyzine Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxyzine Hydrochloride is a first‑generation antihistamine that acts on histamine‑mediated conditions. - Allergic rhinitis: reduces nasal itching, sneezing, and congestion. - Urticaria: alleviates hives and itching. - Anxiety: provides short‑term relief of tension and nervousness. - Sedation: induces calmness before procedures or for sleep support. - Nausea and vomiting: helps control symptoms associated with motion or medication‑induced emesis.

Hydroxyzine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dry mouth: reduced salivation leading to thirst. - Blurred vision: temporary difficulty focusing. - Constipation: slowed gastrointestinal motility. - Headache: mild to moderate cranial pain.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmias: irregular heart rhythms. - Seizures: convulsive episodes in susceptible individuals. - Anaphylaxis: life‑threatening allergic response. - Blood dyscrasias: abnormal blood cell counts, including agranulocytosis.

Before using Hydroxyzine, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Elderly patients: monitor for enhanced sedation and falls. - Driving or operating machinery: avoid until the effect on alertness is known. - Concomitant CNS depressants: assess risk of additive drowsiness. - Renal or hepatic impairment: dose adjustment may be required. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Hydroxyzine can interact with several medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound sedation. - Anticholinergic agents (e.g., atropine, tricyclic antidepressants): increase dry‑mouth and constipation. - MAO inhibitors: risk of hypertensive reactions when combined with certain sympathomimetics.

Moderate Interactions (Monitor Closely):\n- Alcohol: enhances drowsiness and impairment. - Opioid analgesics: additive central nervous system depression. - Other antihistamines: may intensify sedation and anticholinergic effects.